Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Cogn Behav Neurol. 2016 Sep;29(3):122–138. doi: 10.1097/WNN.0000000000000104

TABLE 6.

Controlled Studies of Testosterone Supplementation in Cognitively Impaired Older Men with Low Testosterone

Authors, Year N Mean Age
(Range)
Method of T Measurement Baseline T Level
(Cognitive Impairment)
Cognitive
Measures*
Supplementation Method Significant Conclusions
Kenny et al, 2004 11 80
(73–87)
Fasting TT, BT BT < 128 ng/dL
(early cognitive decline)
MEM 1
VS 4, 5
ATT 5, 6
T enanthate intramuscularly 200 mg every 3 weeks for 12 weeks No significant differences in any tests with T
Tan and Pu, 2003 10 72.4
(68–80)
TT, BT TT < 250 ng/dL
(Alzheimer disease)
GLOB 1, 4
VS 4
T enanthate intramuscularly 200 mg every 2 weeks for 1 year Nonsignificant improvement in VS 4 with T
*

Table 1 explains the abbreviated cognitive domains and the numbered cognitive tests.

T = testosterone. TT = total testosterone. BT = bioavailable testosterone.